Specimen Accessioner I
MDxHealth
Summary
The Specimen Accessioner I performs all paperwork and non-technical procedures required to prepare, process, and submit specimens to the laboratory for testing. Responsibilities will include but not limited to: receiving, triaging and accessioning patient samples, distribution of patient reports and specimens to clients, performing quality control of accessions and labeling.
Job description
- Position is onsite in Irvine, CA
- Shift is Tuesday to Saturday from 10:00am to 6:30pm
- 1 to 2 years' experience
- Strong data entry skills
- Ability to troubleshoot specimen issues.
- Ability to communicate specimen questions, concerns and issues with clients, pathology labs and internal departments via telephone, email and facsimile.
- Excellent communication and documentation skills required.
- Attention to detail a must.
- Hiring salary range: $17.50 - $22.00. The actual rate will be determined based on experience and other factors permitted by law.
Requirements
- 1 to 2 years' experience
- Strong data entry skills
- Ability to troubleshoot specimen issues
- Ability to communicate specimen questions, concerns and issues with clients, pathology labs and internal departments via telephone, email and facsimile
- Excellent communication and documentation skills required
- Attention to detail a must
Benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- 401(k) with company match
- Employee discounts
Company overview
MDxHealth is a commercial-stage molecular diagnostics company that specializes in the development and commercialization of epigenetic and other molecular tests for urologic cancers, with a primary focus on prostate cancer. The company's flagship product is the SelectMDx test, a non-invasive urine-based molecular test that helps physicians determine the need for a prostate biopsy in men with elevated PSA levels. MDxHealth utilizes advanced molecular technologies including DNA methylation analysis and gene expression profiling to provide more accurate risk assessment and personalized treatment guidance. The company's diagnostic solutions aim to improve patient outcomes by enabling more precise diagnosis and reducing unnecessary invasive procedures. With operations in both the United States and Europe, MDxHealth is positioned as a leader in the field of urologic molecular diagnostics, offering innovative testing solutions that address critical clinical decision points in cancer management.